Common diabetic therapy reduces risk of pancreatic cancer, study finds

Taking the most commonly-prescribed anti-diabetic drug, metformin, reduces an individual's risk of developing pancreatic cancer by 62 percent, according to research from The University of Texas M. D. Anderson Cancer Center, published in the Aug. 1 issue of Gastroenterology.

Read the whole article on Physorg

More from Physorg